The FDA has cleared the additional indication of corneal flap creation in refractive surgical procedures for a femtosecond laser platform (LenSx Laser, Alcon).
Ocuphire Pharma submits New Drug Application to FDA for Nyxol eye drops for reversal of mydriasis
New potential mechanism for vision loss discovered
Retinal cells may have potential to protect themselves from diabetic retinopathy
